Get the Stockscreener App
0.1206
1.47%
-0.0018
Pre-market:
.12
-0.0006
-0.50%
Zomedica Corp Stock (ZOM) Latest News
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - ACCESS Newswire
Major Diagnostic Breakthrough: Zomedica's New Dual-Action ACTH Test Transforms Equine Healthcare - StockTitan
Experts predict Zomedica Corp’s (ZOM) current quarter earnings growth rate - US Post News
Zomedica Corp (ZOM) rating initates by Dawson James - Knox Daily
Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared - ACCESS Newswire
Zomedica (NYSEAMERICAN:ZOM) Trading Up 1.6%Still a Buy? - MarketBeat
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians - ACCESS Newswire
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line - ACCESS Newswire
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels - ACCESS Newswire
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - ACCESS Newswire
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - ACCESS Newswire
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s What Happened - Defense World
Geode Capital Management LLC Buys 321,395 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) - Defense World
Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s Why - Defense World
Zomedica (NYSEAMERICAN:ZOM) Shares Down 2.2%Should You Sell? - MarketBeat
Zomedica enters license and supply agreement with Cresilon Inc. - DVM 360
Zomedica Secures Exclusive U.S. Rights to Revolutionary Vetigel Bleeding Control Technology - StockTitan
Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health - AOL
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - AccessWire
Zomedica Expands TRUFORMA Platform with Breakthrough 20-Minute Cardiac and Breeding Diagnostic Tests - StockTitan
Zomedica appoints Scott Jordan as EVP, finance & CFO - MSN
Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8% – Here’s Why - Defense World
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - AccessWire
Zomedica Strengthens Leadership: Industry Veteran with 30+ Years Experience Named New CFO - StockTitan
Zomedica (NYSEAMERICAN:ZOM) Trading Down 2.8%Should You Sell? - MarketBeat
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - AccessWire
Zomedica CEO to Present at NobleCon20 Conference, Investor Meetings Scheduled - StockTitan
Zomedica secures new lease for headquarters expansion By Investing.com - Investing.com South Africa
Zomedica secures new lease for headquarters expansion - Investing.com
Noble Financial Predicts Zomedica FY2024 Earnings - MarketBeat
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - AccessWire
Zomedica Launches 18-Minute Equine Insulin Test, Expands TRUFORMA Platform Capabilities | ZOM Stock News - StockTitan
Johnny D. Powers Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) Stock - MarketBeat
Zomedica (NYSEAMERICAN:ZOM) Stock Rating Upgraded by Noble Financial - MarketBeat
Noble Capital Markets Initiates Equity Research Coverage on Zomedica - WICZ
Zomedica (ZOM) Launches Noble Capital Markets Coverage to Boost Market Visibility | ZOM Stock News - StockTitan
Zomedica initiated with an Outperform at Noble Capital - TipRanks
Zomedica Corp. (AMEX:ZOM) Q3 2024 Earnings Call Transcript - Insider Monkey
Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Earnings call: Zomedica reports record Q3 revenue, eyes future growth By Investing.com - Investing.com Australia
Zomedica stock plunges to 52-week low of $0.12 amid market challenges By Investing.com - Investing.com South Africa
Earnings call: Zomedica reports record Q3 revenue, eyes future growth - Investing.com
Zomedica’s Revenue Up 10% Amid Global Expansion - TipRanks
Zomedica stock plunges to 52-week low of $0.12 amid market challenges - Investing.com India
Zomedica CEO to Present at Sidoti Micro Cap Conference, Showcases Pet Health Innovation | ZOM Stock News - StockTitan
Zomedica Corp Posts Increased Revenue Amid Loss - TipRanks
Zomedica Announces Third Quarter 2024 Financial Results: Revenue - WICZ
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - AccessWire
Zomedica Q3 Revenue Jumps 10%, Diagnostics Surges 38% Despite Wider Losses | ZOM Stock News - StockTitan
Zomedica stock plunges to 52-week low at $0.12 amid market challenges - Investing.com India
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):